Fosun-backed CQP unit to acquire Tasly Pharma for $210m

Fosun-backed CQP unit to acquire Tasly Pharma for $210m

18 June, 2020

C.Q.Pharmaceutical Holding fosun pharma Tasly Holding Group

Printed by Unregistered user on Fri, 19 Dec 2025 16:40:27 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

China's Fosun Pharma in the running for $2b Novartis assets

China's Tasly Pharma said to mull listing biotech unit in $1b Hong Kong IPO

Read more from Greater China

Chinese humanoid robot developer Galbot raises $300m at $3b valuation

China’s Momenta partners Grab for autonomous driving in SE Asia